Position in AUPH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,386,787
+$647,292 QoQ
Shares Held
317,430
-0.7% QoQ
Ownership
0.239%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#40
of 279 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Derivatives in AUPH
reported options exposure · as of Dec 31, 2024CallValue
$391,528
CallShares
43,600
PutValue
$169,722
PutShares
18,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. AUPH ranks #51 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in AUPH
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,386,787 | 317,430 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,739,495 | 319,804 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,082,230 | 444,027 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $6,140,451 | 555,697 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,098,946 | 483,937 | Shares | Defined | 2025-08-27 | |
| 2025-03-31 | $1,317,056 | 163,813 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $1,047,041 | 116,597 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $169,722 | 18,900 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $391,528 | 43,600 | Call | Defined | 2025-02-14 | |
| 2023-06-30 | $222,068 | 22,941 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $212,580 | 19,396 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $171,344 | 39,663 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $263,169 | 34,996 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $2,811,671 | 227,114 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,108,179 | 92,181 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,012,513 | 45,753 | Shares | Defined | 2021-11-15 | |
| 2020-03-31 | $509,068 | 35,084 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||